Amarantus Bioscience Holdings Inc (AMBS)

[Skeetz99]

Per JN recent write-up; I am trying to figure out who current has ownership of the Eltoprazine IND's for ADHD and Schizophrenia. Does AMBS now have complete ownership and rights to these IND's (its not clear based on the PD LID transaction).

If AMBS does own these IND's as well; it would be informative to know when these IND's were filed and how close the FDA is to granting possible approval:

Zacks article writeup:

"We expect Amarantus to look to push into a Phase 2b clinical trial with eltoprazine during the second half of 2014. Given the history and interest of the molecule by the MJFF, we would not be surprised to see Amarantus pursue grant funding to help off-set the cost of this study. Based on plans we’ve seen from Addex and Novartis, Amarantus should be able to move into Phase 2b targeting ~150 patients for around $5 million all-in. Management is currently in the process of identifying centers and selecting a principal investigator for the study. IND’s have already been filed on eltoprazine in ADHD and schizophrenia, with clinical trial agreement (CTA) and medical products agency (MPA) agreement filed in Sweden for PD-LID.